Ceritinib Aggravates Glycemic Control in Insulin-treated Patients with Diabetes and Metastatic ALK-positive Lung Cancer.

Name: Ceritinib Aggravates Glycemic Control in Insulin-treated Patients with Diabetes and Metastatic ALK-positive Lung Cancer.
Author: Sakuma, Ikki

Ceritinib Aggravates Glycemic Control in Insulin-treated Patients with Diabetes and Metastatic ALK-positive Lung Cancer. — المؤلف: Sakuma, Ikki — Internal medicine (Tokyo, Japan) 20190503

المؤلف: Sakuma, Ikki
النشر: Internal medicine (Tokyo, Japan) 20190503
الوصف: 817-820 p.
الموضوعات: Aged؛ Anaplastic Lymphoma Kinase؛ Antineoplastic Agents؛ Biomarkers؛ Biomarkers, Tumor؛ Blood Glucose؛ Carcinoma, Non-Small-Cell Lung؛ Diabetes Mellitus, Type 2